MeSH Browser

MeSH Heading: Parasympatholytics
Tree Number(s): D27.505.696.663.050.650
Unique ID: D010276
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D010276
Annotation: note entry term PARASYMPATHOLYTIC EFFECT: use only for the parasympatholyic effect of a chemical substance
Scope Note: Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
Entry Term(s): Antispasmodic; Antispasmodic Agent; Antispasmodic Agents; Antispasmodic Drug; Antispasmodic Drugs; Antispasmodic Effect; Antispasmodic Effects; Antispasmodics; Parasympathetic-Blocking Agent; Parasympathetic-Blocking Agents; Parasympatholytic; Parasympatholytic Agent; Parasympatholytic Agents; Parasympatholytic Drug; Parasympatholytic Drugs; Parasympatholytic Effect; Parasympatholytic Effects; Spasmolytic; Spasmolytics
NLM Classification #: QV 132
See Also: Anti-Ulcer Agents; Antiparkinson Agents; Muscarinic Antagonists; Muscle Relaxants, Central
Public MeSH Note: ANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69
Online Note: use PARASYMPATHOLYTICS to search ANTISPASMODICS & SPASMOLYTICS 1970-76; use MUSCLES 1966-69
History Note: ANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69
Date Established: 1960/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0015923
Scope Note: Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
Terms: Parasympatholytics Preferred Term
Term UI T030343
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1966); Parasympatholytic Agent
Term UI T000997753
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Parasympatholytic Drug
Term UI T000997754
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Parasympatholytic Agents
Term UI T030344
Date04/06/1994
LexicalTag NON
ThesaurusID NLM (1995); Parasympatholytic Drugs
Term UI T030345
Date04/06/1994
LexicalTag NON
ThesaurusID NLM (1995); Parasympatholytic
Term UI T000997751
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Parasympathetic-Blocking Agent
Term UI T000997752
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Parasympathetic-Blocking Agents
Term UI T030342
Date03/30/1974
LexicalTag NON
ThesaurusID UNK (19XX)

Concept UI: M0015924
Terms: Antispasmodics Preferred Term
Term UI T030346
Date07/16/1975
LexicalTag NON
ThesaurusID UNK (19XX); Antispasmodic Drug
Term UI T000997756
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Spasmolytic
Term UI T000997758
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Antispasmodic Agents
Term UI T030348
Date11/30/1994
LexicalTag NON
ThesaurusID NLM (1996); Antispasmodic Drugs
Term UI T030349
Date11/30/1994
LexicalTag NON
ThesaurusID NLM (1996); Spasmolytics
Term UI T030347
Date07/16/1975
LexicalTag NON
ThesaurusID UNK (19XX); Antispasmodic Agent
Term UI T000997755
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021); Antispasmodic
Term UI T000997750
Date11/19/2019
LexicalTag NON
ThesaurusID NLM (2021)

Parasympatholytics MeSH Descriptor Data 2024